FDA issues guidance compounded GLP-1 production limits, restricting pharmacies to compound only during active shortages to ensure drug safety and ...

Health Secretary Robert F. Kennedy Jr. is a self-professed “big fan” of peptides. They have grown in popularity for wellness ...

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.

The world of peptides has exploded in wellness circles, but the benefits of injecting these gray-market molecules rest on ...

With Health Secretary Robert F. Kennedy Jr. declaring himself “a big fan of peptides,” the FDA has arranged an advisory ...

You’ve probably seen compounding making headlines recently, and not for the right reasons. From so-called “personalized” GLP-1s flooding the market to telehealth startups touting hormone “rebalancing” ...

The post RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work.

Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 ...

The U.S. 503B compounding pharmacies market size is calculated at USD 1.35 billion in 2026 and is expected to reach around ...